Molecular mechanism of malignant transferring of tumors dus to lack of oxygen

World Chinese Journal of Digestology

Volumn 9, Issue 11, 2001, Pages 1300-1304

  Huang, G Y ^a   Yang, L Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ANGIOPOIETIN 1; ANGIOSTATIN; EPHRIN; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

CARCINOGENESIS; DNA RESPONSIVE ELEMENT; HUMAN; HYPOXIA; HYPOXIA RESPONSE ELEMENT; MALIGNANT TRANSFORMATION; REVIEW;

EID: 0035202098     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Tumor hypoxia and gene expression
2. Angiogenesis in cancer and other diseases
3. Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation
4. Risk factor, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
5. Arterial chemoem bolization for hepatocellular carcinoma
6. Staged surgical resection of hepatocellular carcinoma after TAE: A report of 38 cases
7. Segmental transcatheter arterial embolization for primary hepatocellular carcinoma
8. Progress in research of liver surgery in China
9. Clinical research advances in primary liver cancer
10. Hypoxia-inducible expression of tumor-associated carbonic anhydrases
11. New isoforms of VEGF are translated from alternative initiation CUG codons located in its 5′UTR
12. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix
13. Side effects and complications of hepatic arterial infusion and embolization of liver carcinoma in aged patients and its management
14. Hypoxic signal transduction in critical illness
15. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
16. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
17. Increased expression of hypoxia inducible factor-1α in rat and human prostate cancer
18. Coordinate upregulation of hypoxia inducible factor(HIF)-1α and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing
19. Expression of hypoxia-inducible factor-1a: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer
20. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
21. Gene transfer of antisense hypoxia inducible factor-la enhances the therapeutic efficacy of cancer immunotherapy
22. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis
23. 2-regulated prolyl hydroxylation
24. Coordinate upregulation of hypoxia inducible factor (HIF)-1a and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing
25. iNOS expression inhibits hypoxia-inducible factor-1 activity
26. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
27. Intersection of interferon and hypoxia signal traneduction pathways in nitric oxide-induced tumor apoptosis
28. Contrasting effects on HIF-1a regulation by diseasecausing pVHL mutations correlate with patterns of tumouri-genesis in von Hippel-Lindau disease
29. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
30. HIF-1a is required for solid tumor formation and embryonic vascularisation
31. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth
32. Microenvironment-induced cancer metastasis
33. Vascular-specific growth factors and blood vessel formation
34. Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice
35. Significance of vascular endothelial growth factor messenger RNA expression in gastric cancer
36. Detection of angiogenic growth factors in patients with precancerous and cancerous lesions of esophagus front high-risk area in Henan, China
37. Recurrence or metastasis of HCC: Predictors, early detection and experimental antiangiogenic therapy
38. Expression of VEGF121 in gastric carcinoma MGC803 cell line
39. Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma
40. Reduction of tumorigenicity of SMMC7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy
41. Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma
42. Angiogenesis and prostate cancer: Identification of a molecular progression switch
43. Chinese source
44. Paracrine upregulation of VEGF receptor m RNA in endothelial cells by hypoxia-exposed HepG2 cells
45. Thrombospondin-1 is downregulated by anoxia and suppress tumorigenicity of human glioblastoma cells
46. Hypoxia and interleukin-1β stimulate vascular endothelial growth factor production in human proximal tubular cells
47. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1 alpha (hypoxia response element (VEGF cascade differentially regulates vascular response and growth rate in tumors
48. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells
49. Effects of VEGF(165) and VEGF(121) on vasculogenesis and angiogenesis in cultured embryonic quail hearts
50. Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2alpba
51. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines
52. Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular micro-environment
53. VEGF is upregulated in a neuroblastoma and hepatocyte coculture model
54. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
55. Cloning and identification of an angiostatic molecule IP10/crg-2
56. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells
57. Erythrodermic cutaneous T-cell lymphoma with disseminated pustulosis. Production of high levels of interleukin-8 by tumour cells
58. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells
59. Acidic PH-induced elevation in interleukin-8 expression by human ovarian carcinoma cells
60. Anoxia-induced upregulation of interleukin-8 in human malignant melanoma: A potential mechanism for high tumor aggressiveness
61. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
62. Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors
63. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
64. Both platelet-derived growth factor receptor (PDGFR)-alpha and PDGFR-beta promote murine fibroblast cell migration
65. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors
66. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
67. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo
68. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation
69. Regulation of tumor growth and metastasis by thrombo-spondin-1
70. The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts
71. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells
72. The plasma level of nitric oxide and the expression of inducible nitric oxide synthase in human hepatocellular carcinoma
73. Expression of nitric oxide synthase protein and gene in the splanchnic organs of liver cirrhosis and portal hypertensive rats
74. Expression of inducible nitric oxide synthase in human gastric cancer
75. Roles of nitric oxide in tumour growth
76. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murinee fibrosarcoma cells carrying mutant p53
77. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors
78. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxidemediated decrease in protein kinase C delta activity
79. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1
80. Endothelial heme oxygenase-1 induction by hypoxia: Modulation by inducible nitric-oxide synthase and s-nitrosothiols
81. Functional requirement of the hypoxia responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine
82. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines
83. Adrenomedullin expression in human tumor cell lines: Its potential role as an autocrine growth factor
84. Hypoxia-induced adrenomedullin production in the kidney
85. Induction of adrenomedullin by hypoxia and cobalt chloride in human colorectal carcinoma cells
86. Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro
87. Genetic instability induced by the tumor microenvironment
88. A new role for hypoxia in tumor progression: Induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs
89. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
90. Hypoxic cervical cancers with low apoptotic index are highly aggressive
91. Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SVITa22
92. A novel cDNA fragment associated with gastric cancer drug resistance was screened out from a library by monoclonal antiboby MGr1
93. Overexpression of p-glycoprotein in hepatocellular carcinoma and its clinical implication
94. Expression of lung resistance in patiets with gastric carcinoma and its clinical significance
95. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs